A detailed history of Murphy Capital Management Inc transactions in Amgen Inc stock. As of the latest transaction made, Murphy Capital Management Inc holds 8,857 shares of AMGN stock, worth $2.48 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares
8,857
Previous 9,107 2.75%
Holding current value
$2.48 Million
Previous $2.2 Million 2.18%
% of portfolio
0.3%
Previous 0.25%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 13, 2022

SELL
$230.71 - $256.74 $57,677 - $64,185
-250 Reduced 2.75%
8,857 $2.15 Million
Q1 2022

Apr 06, 2022

SELL
$219.27 - $242.57 $47,143 - $52,152
-215 Reduced 2.31%
9,107 $2.2 Million
Q4 2021

Jan 10, 2022

BUY
$198.88 - $227.6 $38,781 - $44,382
195 Added 2.14%
9,322 $2.1 Million
Q3 2021

Oct 22, 2021

SELL
$212.27 - $248.7 $85,120 - $99,728
-401 Reduced 4.21%
9,127 $1.94 Million
Q2 2021

Jul 26, 2021

BUY
$233.58 - $259.14 $11,912 - $13,216
51 Added 0.54%
9,528 $2.32 Million
Q1 2021

Apr 21, 2021

BUY
$221.91 - $258.6 $64,797 - $75,511
292 Added 3.18%
9,477 $2.36 Million
Q4 2020

Feb 05, 2021

BUY
$216.38 - $257.67 $54,095 - $64,417
250 Added 2.8%
9,185 $2.11 Million
Q3 2020

Oct 20, 2020

SELL
$234.65 - $260.95 $133,750 - $148,741
-570 Reduced 6.0%
8,935 $2.27 Million
Q2 2020

Aug 03, 2020

BUY
$197.81 - $242.74 $19,781 - $24,274
100 Added 1.06%
9,505 $2.24 Million
Q1 2020

Apr 28, 2020

SELL
$182.24 - $241.7 $21,504 - $28,520
-118 Reduced 1.24%
9,405 $1.91 Million
Q4 2019

Feb 10, 2020

SELL
$189.21 - $243.2 $32,544 - $41,830
-172 Reduced 1.77%
9,523 $2.3 Million
Q3 2019

Oct 11, 2019

SELL
$174.11 - $208.62 $44,223 - $52,989
-254 Reduced 2.55%
9,695 $1.88 Million
Q2 2019

Jul 22, 2019

SELL
$166.7 - $195.41 $28,338 - $33,219
-170 Reduced 1.68%
9,949 $1.83 Million
Q1 2019

Apr 11, 2019

SELL
$180.87 - $203.88 $130,226 - $146,793
-720 Reduced 6.64%
10,119 $1.92 Million
Q4 2018

Feb 04, 2019

SELL
$178.4 - $208.25 $79,566 - $92,879
-446 Reduced 3.95%
10,839 $2.11 Million
Q3 2018

Oct 10, 2018

BUY
$185.29 - $208.89 $47,063 - $53,058
254 Added 2.3%
11,285 $2.34 Million
Q2 2018

Jul 26, 2018

SELL
$166.05 - $186.51 $72,563 - $81,504
-437 Reduced 3.81%
11,031 $2.04 Million
Q1 2018

Apr 17, 2018

SELL
$169.43 - $198.0 $45,746 - $53,460
-270 Reduced 2.3%
11,468 $1.96 Million
Q4 2017

Jan 29, 2018

BUY
$168.79 - $188.59 $5,232 - $5,846
31 Added 0.26%
11,738 $2.04 Million
Q3 2017

Oct 19, 2017

BUY
$167.29 - $191.0 $1.96 Million - $2.24 Million
11,707
11,707 $2.18 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $150B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Murphy Capital Management Inc Portfolio

Follow Murphy Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Murphy Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Murphy Capital Management Inc with notifications on news.